GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Young Investigator Awards Session in Thrombosis
